|
Posted: JULY 10, 2007
CSMG
Technologies, Inc. Announces Ukraine Tissue Welding
Patent Issued
Corpus Christi, TX, July 10, 2007 -- CSMG Technologies,
Inc., (OTC Bulletin Board: CTUM
- News)
a technology management company, announced today the
company has received a patent from Ukraine for "Method
For Welding of Biological Tissue, Control Method For
Welding Tissue (variants) and Apparatus For Biological
Tissue Welding (variants)." This approval follows the
U.S. patent approval. The technology was invented and
developed at the internationally renowned E.O. Paton
Institute of Electric Welding, National Academy of Sciences
of Ukraine, Kiev, Ukraine, headed by Professor B.E.
Paton. U.S., Australian, Canadian and European Union
patents have been issued, and additional U.S. and foreign
patents are pending, all owned by LTC.
CSMG owns the technology and exclusive world rights
to the live tissue bonding device through Live Tissue
Connect, Inc., a subsidiary corporation formed for the
development and exploitation of the platform technology.
About CSMG Technologies, Inc
CSMG Technologies is a technology management company
that finances, owns, develops, licenses and markets
innovative advanced technologies and business opportunities
created in the Ukraine through a network of scientific
institutes and private organizations. CSMG is focused
on two primary subsidiaries, Live Tissue Connect, Inc.
and landfill gas processing.
For further information on CSMG Technologies and its
various subsidiaries, please visit our website at www.ctum.com.
Sign up to receive CSMG Technologies automated email
press releases and other notifications: Please go to
http://www.ctum.com/contact_information.html
and fill-in information.
This press release may contain forward-looking
information within the meaning of Section 21E of the
Securities Exchange Act of 1934 as amended (the Exchange
Act), including all statements that are not statements
of historical fact regarding the intent, belief or current
expectations of the company, its directors or its officers
with respect to, among other things: (i) the company's
financing plans; (ii) trends affecting the company's
financial condition or results of operations; (iii)
the company's growth strategy and operating strategy;
and (iv) the declaration and payment of dividends. The
words "may," "would," "will," "expect," "estimate,"
"anticipate," "believe," "intend" and similar expressions
and variations thereof are intended to identify forward-looking
statements. Investors are cautioned that any such forward-looking
statements are not guarantees of future performance
and involve risks and uncertainties, many of which are
beyond the company's ability to control, and that actual
results may differ materially from those projected in
the forward-looking statements as a result of various
factors.
CONTACT:
ROI Group Associates, Inc.
Michael Dodge, 212-495-0744
mdodge@roiny.com
or
Bob Giordano, 212-495-0201
CSMG Technologies, Inc. - 500 No. Shoreline # 701 no.
- Corpus Christi, TX 78471
Donald S. Robbins, President and CEO
361-887-7546
K. Bruce Jones
770-955-0409
|
